Data Dividends Program
Earn gift cards for tracking health data and contributing to research
Company profile
Company profile
Folia Health is a digital health platform founded by family caregivers that helps individuals with chronic and rare conditions transform their daily health experiences into structured data insights. The company's mobile app enables users to quickly capture what they call 'home-reported outcomes' (HROs) - observations about symptoms, treatments, flare-ups, and overall wellbeing - in 90 seconds or less. With over 40,000 users who have shared 4.5 million home-reported outcomes, Folia serves as a comprehensive health tracking solution that helps patients spot patterns, understand correlations, and make data-driven decisions about their care. The platform supports all rare and chronic conditions, with specialized in-app customizations for conditions including Paroxysmal Nocturnal Hemoglobinuria (PNH), Eczema, Lupus, Sickle Cell Disease, IgA Nephropathy (IgAN), and High Triglycerides. Users maintain full control over their data and can optionally participate in paid research studies or the Data Dividends program, earning compensation for contributing de-identified data to medical research. For life sciences companies, Folia offers an end-to-end research solution that addresses common real-world data challenges. The platform captures high-fidelity, patient-driven insights about disease heterogeneity, treatment patterns, and therapy impact that traditional clinical endpoints often miss. Services include protocol design, multi-channel recruitment, validated ePRO deployment, data linkage to EMR and claims data, and comprehensive analysis and reporting. The company's proprietary methodology enables precision outcomes measurement by capturing health experiences in near real-time outside clinical settings, providing a more complete understanding of patient phenotypes and response to therapy.
Company description Folia Health official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Recorded integration context: Claims data, EMR, Registry data, Wearables.
Company milestones
Active research studies including BRAVE-PWS Caregiver Study, CIDP Compass Study, IgAN Bridge Study, PNH Study, and Connect C3G Study. Data Dividends program offering $4/month for users who share data for research.
Partnerships
No partners are currently listed.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Earn gift cards for tracking health data and contributing to research
Health tracking app transforming lived experiences into structured data insights for chronic conditions
End-to-end outcomes research platform for heterogeneous conditions using home-reported outcomes
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Annals of the American Thoracic Society · Aug 5, 2026
Baseline Characteristics and Self-Reported Use of Chronic Daily Therapies of the Home Reported Outcomes With CFTR Modulator Therapy (HERO-2) Cohort.Pediatric pulmonology · Jul 1, 2025
Correction to: Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2.BMC infectious diseases · Jul 1, 2021
Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2.BMC infectious diseases · Jun 16, 2021
Clinical validation
NCT04798014 · Sponsor · COMPLETED
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Captured from user community
Active users tracking health on platform
Time to capture daily health observations
Demonstrating full therapy value beyond traditional clinical endpoints for approval and reimbursement
Bridged disconnect between endpoints needed for Approval vs. Reimbursement
Gaining insights beyond traditional PROs without relying on long recall periods
Provides nuanced insights not available from traditional PROs with reduced recall bias
05 · Leadership
Leadership profiles and professional links from the current Company record.
Nell Meosky Luo
Team Member
06 · Company updates
Recent articles published on Folia Health's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.